SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, announces that its CyPath® ...

COPENHAGEN, Denmark — Screening individuals for lung cancer with low-dose CT without preselection based on their risk profile is associated with a substantial reduction in lung cancer-specific ...

bioAffinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung ...

©2026 FOX News Network, LLC. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All market data delayed 20 minutes.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Shira Boehler's MRI results showing an abnormality in right lung At 43, Shira Boehler ...

In a recent opinion piece published in the journal Trends in Cancer, researchers examined the rising global burden of lung cancer in people with no history of smoking. This phenomenon requires its own ...

April marks National Cancer Prevention and Early Detection Month, and the American Lung Association is kicking it off by offering free lung cancer screenings to District residents in Southeast ...

BEIJING, 4 February (BelTA - China Daily) - A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including ...

DULUTH, Minn. — Essentia Health is combating lung cancer by expanding access to early detection screenings with state-of-the-art equipment. From more staff and hours to a new robot, the Lung Nodule ...